[PDF] Top 20 Development and In Vitro Evaluation of Sustained Release Matrix Tablets of Losartan Potassium

... oral sustained release formulations through matrix tablets for the widely used Losartan potassium is a potent, highly specific angiotensin II type 1 (AT1) receptor antagonist ... See full document

... of Losartan potassium using different polymers such as HPMC, EC, Chitosan and PVP had shown good promising result for all the evaluated ...in- vitro drug release and drug content, formulation ... See full document

... Administration of a drug via the buccal mucosa (the lining of the cheek) to the systemic circulation is defined as buccal delivery. Despite, the buccal mucosa is significantly less permeable than the sublingual mucosa ... See full document

... industry sustained release dosage forms provide multiple commercial ...the development of new drug delivery system rather than invention of new ...the development cost for new drug molecule is ... See full document

... Drug Release [11&12] : To study the mechanism of drug release from the matrix tablets, the drug release data were fitted to various kinetic models like zero order, first order, ... See full document

... Floating matrix tablets of metformin hydrochloride were developed and evaluated for increase bioavailability by increasing gastric residence time and sustained release of drug on the upper ... See full document

... designed sustained or controlled release drug delivery system can be a major advance towards solving this problem 2 .... Losartan potassium is an orally active angiotensin II receptor ... See full document

... Drug Content: Ten tablets were weighed and average weight is calculated. All tablets were crushed and powder equivalent to 6 mg drug was dissolved in 6 ml of 0.1N NaOH and the volume was made up to 100 ml ... See full document

... In Vitro-Release Testing [13,14] : The in-vitro release pattern of sustained release matrix tablets was studied as per method given by Chaudhari et al ...of ... See full document

... in vitro release of losartan potassium from pellets was measured using basket type dissolution ...apparatus. Losartan potassium pellets equivalent to 40 mg were filled in to ... See full document

... of tablets were found to be in the range of ...for tablets ranged from ...the tablets passed weight variation test as the % weight variation was within the Pharmacopoeial ...of tablets was ... See full document

... of sustained release dosage form is increasing throughout the ...as release modifier to control the drug release from the ...good sustained release formulation of Ramipril using ... See full document

... Adhiparasakthi college of pharmacy, Melmaruvathur. 45 (GLZ) BCS class II drug, is an oral antihyperglycemic agent used for the treatment of non- insulin-dependent diabetes mellitus However, low aqueous solubility and ... See full document

... Losartan potassium is an orally active non-peptide angiotensin - II receptor antagonist used in the treatment of hypertension due to mainly blockade of AT1 receptors 8 ...Conventional tablets should ... See full document

... 21. Higuchi T. Mеchanism of sustainеd-action mеdication: thеorеtical analysis of ratе of Rеlеasе of solid drugs disреrsеd in solid matricеs. J. Рharm. Sci., 1961; 52(1): 1145–9. 22. Zaltе H, Saudagar r. Rеviеw on ... See full document

... the release of drug from the floating matrix ...drug release from formulations F10, F11, and F12 was ...to release the drug within the desired time and difference in the drug release ... See full document

... Matrix tablets were developed using albizia gum for investigating it‟s suitability for the controlled release using losartan potassium as a model ...drug. Tablets were prepared ... See full document

... and release characteristic of a bilayer matrix tablet containing Glimepride immediate release component and Metformin hydrochloride as sustained release ...Immediate release ... See full document

... breakage. Losartan Potassium is an orally active non- peptide Angiotensin-2 receptor antagonist used in treatment of ...Acetonitrile. Losartan potassium has half life of ...immediate ... See full document

... Core tablets of 120 mg weight were prepared by direct compression method using 7 mm concave punch with single station tablet compression machine (Anant electrical, ...core tablets were prepared, one ... See full document